Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aspen Aerogels (ASPN) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to $24.1 million.

  • Aspen Aerogels' Operating Expenses fell 2368.93% to $24.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $409.2 million, marking a year-over-year increase of 22952.24%. This contributed to the annual value of $128.4 million for FY2024, which is 2095.47% up from last year.
  • Per Aspen Aerogels' latest filing, its Operating Expenses stood at $24.1 million for Q3 2025, which was down 2368.93% from $30.5 million recorded in Q2 2025.
  • Aspen Aerogels' Operating Expenses' 5-year high stood at $322.2 million during Q1 2025, with a 5-year trough of $10.1 million in Q1 2021.
  • In the last 5 years, Aspen Aerogels' Operating Expenses had a median value of $24.1 million in 2025 and averaged $39.3 million.
  • Data for Aspen Aerogels' Operating Expenses shows a peak YoY increase of 88496.65% (in 2025) and a maximum YoY decrease of 2368.93% (in 2025) over the last 5 years.
  • Aspen Aerogels' Operating Expenses (Quarter) stood at $14.6 million in 2021, then soared by 63.87% to $24.0 million in 2022, then increased by 17.65% to $28.2 million in 2023, then increased by 14.82% to $32.4 million in 2024, then decreased by 25.52% to $24.1 million in 2025.
  • Its Operating Expenses was $24.1 million in Q3 2025, compared to $30.5 million in Q2 2025 and $322.2 million in Q1 2025.